TABLE 2

Autoantibody biomarkers of autoimmune encephalitis: Cell-surface and synaptic antibodies

ANTIBODYCENTRAL NERVOUS SYSTEM FEATURESPERIPHERAL NERVOUS SYSTEM FEATURESOTHER FEATURESASSOCIATED MALIGNANCY
AMPARLimbic encephalitisSCLC Breast carcinoma Thymoma
Caspr2Limbic encephalitisPeripheral nerve hyperexcitabilityRare, but thymoma carcinoma reported
DPPXEncephalopathy MyelopathyGI dysmotility Sleep disorderRare, but lymphoma reported
D2RParkinsonism
Encephalitis
GABA A receptorEncephalitis
Status epilepticus
Thymoma
GABA B receptorLimbic encephalitis
Status epilepticus
Opsoclonus myoclonus
SCLC
GQ1bBickerstaff brain stem encephalitisGuillain-Barré-like illness
IgLON5Sleep disorder
Dementia
Dysphagia Respiratory failureRare
LGI1Limbic encephalitis
Faciobrachial dystonic seizures
Thymoma
NMDA-RLimbic encephalitis
Status epilepticus
Movement disorders
Psychosis
Catatonia
Ovarian teratoma
mGluR1
mGluR5
Glycine receptor
Cerebellar ataxia
Limbic encephalitis
Stiff-person spectrum disorder
DysgeusiaHodgkin lymphoma
Hodgkin lymphoma
Rare
  • AMPAR = 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl) propanoic acid receptor; Caspr2 = contactin-associated protein-like 2; D2R = dopamine 2 receptor; DPPX = dipeptidyl-peptidase-like protein 6; GABA = gamma-aminobutyric acid; GI = gastrointestinal; LGI1 = leucine-rich glioma-inactivated 1; mGluR = metabotropic glutamate receptor; NMDA-R = anti-N-methyl-D-aspartate receptor; SCLC = small cell lung cancer